A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

February 2, 2023

Primary Completion Date

June 19, 2025

Study Completion Date

May 28, 2028

Conditions
Primary Immune Thrombocytopenia
Interventions
BIOLOGICAL

Ianalumab

Concentrate for solution for infusion for intravenous use

DRUG

Eltrombopag

Film-coated tablet for oral use

DRUG

Placebo

Concentrate for solution for infusion for intravenous use.

Trial Locations (77)

1102

Novartis Investigative Site, Quezon

1229

Novartis Investigative Site, Makati City

4032

Novartis Investigative Site, Debrecen

5530

Novartis Investigative Site, Yvoir

6800

Novartis Investigative Site, Ankara

8800

Novartis Investigative Site, Roeselare

10050

Novartis Investigative Site, George Town

10450

Novartis Investigative Site, George Town

10461

Montefiore Medical Center, The Bronx

10700

Novartis Investigative Site, Bangkok

10960

Hematology Oncology Association of Rockland, Nyack

15706

Novartis Investigative Site, Santiago Compostela

25230

Novartis Investigative Site, Saltillo

33305

Novartis Investigative Site, Taoyuan District

34098

Novartis Investigative Site, Istanbul

34129

Novartis Investigative Site, Trieste

35100

Novartis Investigative Site, Izmir

37007

Novartis Investigative Site, Salamanca

40138

Novartis Investigative Site, Bologna

41000

Novartis Investigative Site, Blois

47500

Novartis Investigative Site, Subang Jaya

48334

Michigan Center of Medical Research, Farmington Hills

50200

Novartis Investigative Site, Chiang Mai

50937

Novartis Investigative Site, Cologne

55200

Novartis Investigative Site, Samsun

58260

Novartis Investigative Site, Morelia

59102

St Vincent Frontier Cancer Center, Billings

60201

NorthShore University Health System, Evanston

64460

Novartis Investigative Site, Monterrey

68000

Novartis Investigative Site, Kuala Selangor

72000

Novartis Investigative Site, Le Mans

75251

Texas Oncology, Dallas

80045

University of Colorado Anschutz, Aurora

80100

Novartis Investigative Site, Johor Bahru

84405

Community Cancer Trials of Utah, Ogden

85349

Yuma Regional Medical Center, Yuma

88586

Novartis Investigative Site, Kota Kinabalu

100730

Novartis Investigative Site, Beijing

119074

Novartis Investigative Site, Singapore

169608

Novartis Investigative Site, Singapore

200136

Novartis Investigative Site, Craiova

249203

Novartis Investigative Site, Rishikesh

250012

Novartis Investigative Site, Jinan

256603

Novartis Investigative Site, Binzhou

300020

Novartis Investigative Site, Tianjin

300052

Novartis Investigative Site, Tianjin

300079

Novartis Investigative Site, Timișoara

310003

Novartis Investigative Site, Hangzhou

430022

Novartis Investigative Site, Wuhan

510515

Novartis Investigative Site, Guangzhou

519763

Novartis Investigative Site, Jeollanam

700014

Novartis Investigative Site, Kolkata

02118

Boston Medical Center, Boston

01665

UMASS Memorial Medical Center, Worcester

C1181ACH

Novartis Investigative Site, CABA

A 1090

Novartis Investigative Site, Vienna

625 00

Novartis Investigative Site, Brno

100 34

Novartis Investigative Site, Prague

128 08

Novartis Investigative Site, Prague

01307

Novartis Investigative Site, Dresden

Novartis Investigative Site, Dresden

07740

Novartis Investigative Site, Jena

H-1083

Novartis Investigative Site, Budapest

00133

Novartis Investigative Site, Roma

00168

Novartis Investigative Site, Roma

453-8511

Novartis Investigative Site, Nagoya

540-0006

Novartis Investigative Site, Osaka

565 0871

Novartis Investigative Site, Suita

400-8506

Novartis Investigative Site, Kofu

860-0008

Novartis Investigative Site, Kumamoto

2333 ZA

Novartis Investigative Site, Leiden

3584 CX

Novartis Investigative Site, Utrecht

06591

Novartis Investigative Site, Seoul

09100

Novartis Investigative Site, Aydin

E1 1BB

Novartis Investigative Site, London

W12 0HS

Novartis Investigative Site, London

OX3 7LE

Novartis Investigative Site, Oxford

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY